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Abstract  1 
Objectives To describe the laboratory test ordering patterns by general practitioners 2 
(GPs) in Northern Ireland Western Health and Social Care Trust (WHSCT) and explore 3 
demographic and socio-economic associations with test requesting.  4 
Design Cross-sectional study. 5 
Setting Western Health and Social Care Trust, Northern Ireland. 6 
Participants 55 WHSCT primary care medical practices that remained open throughout 7 
the study period 1 April 2011 - 31 March 2016. 8 
Outcomes To identify the temporal patterns of laboratory test ordering behaviour for 8 9 
commonly requested clinical biochemistry tests/test groups in WHSCT. To analyse the 10 
extent of variations in laboratory test requests by GPs and to explore whether these 11 
variations can be accounted for by clinical outcomes or geographical, demographic, and 12 
socioeconomic characteristics.  13 
Results  The median number of adjusted test request rates over five consecutive years 14 
of the study period decreased by 45.7% for urine albumin/creatinine ratio (ACR) (p < 15 
0.000001) and 19.4% for lipid profiles (p < 0.000001) while a 60.6%, 36.6%, and 29.5% 16 
increase was observed for HbA1c (p < 0.000001), immunoglobulins (p = 0.000007), and 17 
PSA (p = 0.0003) respectively. The between-practice variation in test ordering rates 18 
increased by 272% for immunoglobulins (p = 0.008) and  500% for HbA1c (p = 0.0001). 19 
No statistically significant relationship between ordering activity and either demographic 20 
(age and gender) and socioeconomic factors (deprivation) or Quality and Outcome 21 
Framework (QOF) scores was observed. We found the rural-urban differences in 22 
between-practice variability in ordering rates for lipid profiles, thyroid profiles, PSA, and 23 
immunoglobulins to be statistically significant at the Bonferroni-adjusted significance 24 
level p < 0.01.  25 
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Conclusions We explored potential factors of the inter-practice variability in the use of 26 
laboratory tests and found that differences in requesting activity appear unrelated to 27 
either demographic and socioeconomic characteristics of GP practices or clinical 28 
outcome indicators. 29 
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Strengths and limitations of this study 30 
• The study provides a comprehensive analysis of temporal changes in laboratory 31 
test utilization patterns and establishes the extent of variability in test requesting 32 
activity across general practices in Northern Ireland’s Western Health and Social 33 
Care Trust. 34 
• The variation in test ordering, not related to demographic and socioeconomic 35 
characteristics of practices, practice location or clinical outcome indicators, may 36 
reflect inappropriate laboratory test utilization and hence, suggest a potential for 37 
more efficient demand management of laboratory services.  38 
• Given a cohort of general practices within one catchment area, our results 39 
provide evidence of differences in behaviour of individual GPs when managing 40 
patients with similar clinical symptoms. 41 
• Failure to collect and cross-tabulate data on characteristics of general 42 
practitioners (GPs), such as GP’s age, years of experience, medical training was 43 
a study limitation and a missed opportunity in assessing the influence of 44 
practitioner factors on the variation in test ordering behaviour. 45 
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Introduction 46 
Despite the important role of laboratory testing in the diagnosis and monitoring of 47 
disease, there is concern about the increasing number of requested tests and in 48 
particular, large differences in laboratory utilization between clinical teams.1  In the UK, 49 
laboratory test orders grew by approximately 5% per year in recent years and 50 
inappropriate test requests are considered to be an important cause for this increase2,3. 51 
Although pathology expenditures account for only 5–6% of the UK total health budget, 52 
they are viewed as a potential source of savings, most likely because the costs can be 53 
easily identified and measured.4 According to the Department of Health, the 54 
rationalization of pathology services, including demand management of laboratory tests 55 
and elimination of unnecessary requesting, could produce savings of at least £500 56 
million.5 57 
Unnecessary testing is not only wasteful of resources but impacts on patients directly 58 
through the requirement for venepuncture and the follow up of minor (and possibly 59 
insignificant) abnormalities which may cause patient anxiety. On the other hand, 60 
inappropriate under requesting may cause harm through failure to diagnose or manage 61 
disease optimally. Several studies suggested that unnecessary and inappropriate 62 
utilization of laboratory services is closely linked to inter-practitioner variability in test 63 
requesting.6-8 Despite the increased availability of clinical management guidelines 64 
promoting harmonization of the use of laboratory tests, there is still substantial variation 65 
in test utilization among general practitioners.7,9 These differences appear to be 66 
unrelated to demographic characteristics of patient populations, socio-economic status 67 
of GP practices, disease prevalence or clinical outcome indicators.6,7,10,11  Even if some 68 
of these variables have been shown to have an effect on test ordering patterns, the 69 
variation in requesting rates is so large that it can only be explained by differences in 70 
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attitudes towards the use of laboratory tests of individual practitioners.10 Accordingly, 71 
factors such as confidence in clinical judgement, clinical experience, an attitude about 72 
clinical practice guidelines, a lack of knowledge regarding the correct use of tests and 73 
fear of litigation have been identified as potential sources of practice variation.12-15 74 
Since unwarranted variation can lead to suboptimal clinical outcomes,16,17 identification 75 
of factors contributing to differences in test requesting can provide useful information for 76 
optimising utilization of laboratory services. The aim of our study was to establish the 77 
extent of variability in test requesting and characterise temporal changes in test ordering 78 
patterns across general practices within the catchment area of the Northern Ireland (NI) 79 
Western Health and Social Care Trust (WHSCT) for a range of most commonly 80 
requested clinical biochemistry tests/test groups. In addition, we investigated potential 81 
factors associated with inter-doctor variability in the use of laboratory tests including 82 
geographical, demographic, and socioeconomic factors as well as Quality and Outcome 83 
Framework (QOF) scores. 84 
Materials and Methods 85 
Study design and data sources 86 
We conducted a cross-sectional study of laboratory test ordering activity across general 87 
practices in the WHSCT in the period from 1 April 2011 to 31 March 2016. The data on 88 
the use of laboratory tests were obtained from a HSC Business Object XI clinical 89 
information system. We investigated requesting rates for 8 clinical biochemistry 90 
tests/test groups including electrolyte proﬁle, thyroid proﬁle (FT4 and TSH), liver proﬁle, 91 
lipid proﬁle, urine albumin/creatinine ratio (ACR), glycosylated haemoglobin (HbA1c), 92 
prostate-speciﬁc antigen (PSA), and immunoglobulins. The profile tests i.e., electrolyte, 93 
lipid, liver, and thyroid profiles contained a number of different related analytes. 94 
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Individual elements of the profile tests could not be requested separately. Other tests, 95 
such as HbA1c comprised one single analyte. The standardized number of laboratory 96 
tests requested in each general practice was determined by dividing the total number of 97 
requested tests by the number of registered patients and expressed as requests per 98 
1000 patients, with the exception of HbA1c and ACR for which ordering rates were 99 
expressed as tests per patient with diabetes and PSA rates, calculated per 1000 male 100 
patients. GP practice list size data (including the number of patients with diabetes) and 101 
patient demographic data was extracted from the Business Services Organisation (BSO) 102 
Family Practitioner Service Information and Registration Unit system. The rural-urban 103 
distribution of GP practices was based on the data from the Census Office of the 104 
Northern Ireland Statistics and Research Agency (NISRA).18 Socioeconomic 105 
characteristics of GP practices were determined using the NISRA Neighbourhood 106 
Information System (NINIS).19 QOF scores for individual practices were extracted from 107 
the website of the Northern Ireland Department of Health.20  108 
Participants and setting 109 
Data on laboratory tests requested from 55 general practices within the WHSCT were 110 
collected from the laboratory databases of Clinical Chemistry departments of the 111 
Altnagelvin Area Hospital, Tyrone County Hospital, and the Erne Hospital (subsequently 112 
the South West Acute Hospital). WHSCT provides health and social care services 113 
throughout the west of Northern Ireland, across the council areas of Derry City and 114 
Strabane District Council, Limavady in the Causeway Coast and Glens Borough Council, 115 
and Fermanagh and Omagh District Council. 116 
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Inclusion criteria 117 
We examined laboratory test requests from 55 separate primary care medical practices 118 
within the catchment area of WHSCT that remained open throughout the study period 119 
i.e. during five consecutive years: Apr 2011 – Mar 2012, Apr 2012 – Mar 2013, Apr 2013 120 
– Mar 2014, Apr 2014 – Mar 2015, and Apr 2015 – Mar 2016. To ensure the 121 
completeness and consistency of the data, test orders from WHSCT GP practices that 122 
were closed (2 GP practices) or taken over by other practices (1 GP practice) during the 123 
period of investigation were not taken into account.  124 
Variables and characteristics 125 
Our analysis was limited to 8 most frequently requested clinical biochemistry tests/test 126 
groups including electrolyte proﬁle, thyroid proﬁle, liver proﬁle, lipid proﬁle, ACR, HbA1c, 127 
PSA, and immunoglobulins. All considered tests/profiles (with the exception of 128 
immunoglobulins and ACR) were listed on a paper pathology request form and ordered 129 
by ticking a box adjacent to the test name; requests for ACR and immunoglobulins were 130 
made by writing the test name in an open text field.   131 
Rates of test requests were analysed in the context of geographical and socioeconomic 132 
characteristics of practices, patient demographics (age and gender), and clinical 133 
outcome indicators. Note that we were not able to obtain a consolidated data on 134 
both gender and age of patients (i.e., the number of patients split into age bands and 135 
broken down by gender) registered in individual GP practices. 136 
The practice setting (rural v. urban area) was determined using the urban-rural 137 
classification of the Department for Environment, Food and Rural Affairs (DEFRA)21 138 
while the size of settlements was obtained from the NISRA Census Office.18 A GP 139 
practice was defined as rural if its physical address was situated in a settlement of less 140 
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than 10,000. Accordingly, we classified 24 practices as rural and 31 as urban. 141 
Furthermore, GP practices were categorised based on the Northern Ireland Multiple 142 
Deprivation Measure (MDM) identified for individual Super Output Areas (SOAs).19 The 143 
MDM comprises a weighted combination of 7 component measures (Income 144 
Deprivation; Employment Deprivation; Health Deprivation and Disability; Education, 145 
Skills and Training Deprivation; Proximity to Services; Living Environment; and Crime 146 
and Disorder) and ranges from 1 (most deprived SOAs) to 890 (least deprived SOAs). 147 
The Health Deprivation & Disability rank (one of the MDM domains)19 was analysed 148 
separately as a potential factor contributing to inter-doctor variability in the use of 149 
laboratory tests. 150 
Given a detailed breakdown of the age of patients on the individual practice lists, we 151 
examined the relationship between the percentage of patients over age 65 and ordering 152 
rates for electrolyte, thyroid, liver, and lipid proﬁles. In addition, we investigated the link 153 
between gender and requesting activity for PSA (for males) and thyroid profiles (for 154 
females).  155 
To evaluate the impact of test requesting patterns for diabetes mellitus on the QOF 156 
clinical indicator scores in diabetes, we used the overall QOF points under clinical 157 
indicator DM007 (‘The percentage of patients with diabetes in whom the last HbA1c is 59 158 
mmol/mol or less in the preceding 15 months’), DM008 (‘The percentage of patients with 159 
diabetes in whom the last HbA1c is 64 mmol/mol or less in the preceding 15 months’), 160 
and DM009 (‘The percentage of patients with diabetes in whom the last HbA1c is 75 161 
mmol/mol or less in the preceding 15 months’). Specifically, we combined the number of 162 
points for each of these 3 categories, calculated the overall achievement rate, and 163 
investigated its relationship with inter-practitioner variability in test requesting of HbA1c.  164 
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Outcome measures 165 
Our outcome of interest was to identify the presence and extent of variations in primary 166 
care laboratory tests ordering and to evaluate temporal changes in both the standardised 167 
number of test requests and between-practice variability in requesting. In addition, we 168 
studied demographic, socio-economic, geographical, and clinical factors that may 169 
explain this variation.  170 
Statistical analysis 171 
Inter-practice variability in test requests was assessed by calculating the variance (σ²). 172 
Furthermore, we computed ‘variability index’ (Vari) defined as the top decile divided by 173 
the bottom decile of standardized test request rates.10 Vari is a dimensionless measure 174 
of dispersion allowing us to compare the amount of variation in request rates of individual 175 
tests despite their differences in scale. The Shapiro-Wilk test of normality was used to 176 
determine if the distribution of test ordering data deviated from a normal distribution.22 177 
Since the distribution of laboratory test request rates was found to be non-normal, the 178 
non-parametric statistics were implemented to perform further analysis. Mann Whitney 179 
U (MWU) test was employed to compare distributions of laboratory test rates between 180 
GP practices located in rural and urban areas.23 The homogeneity of variances for 181 
requesting activity in rural and urban GP practices was assessed with the Fligner-Killeen 182 
(FK) test.24 Significance of temporal changes in median and variation in test requesting 183 
rates was examined with the Mann–Kendall (MK) test.25 To test the relationship between 184 
adjusted requesting rates and 1) Multiple Deprivation Measure; 2) Health Deprivation & 185 
Disability Deprivation rank; 3) proportions of patients over age 65; 4) distribution of 186 
patient’s gender; and 5) QOF clinical indicator scores, we calculated the Kendall rank 187 
correlation coefficient (τ) with the corresponding p-value.26 The Kendall coefficient (-1 ≤ 188 
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τ ≤ 1 ) measures the strength of a correlation between two variables and assesses the 189 
degree of overall correspondence of variables’ ranking.26  190 
Since the test statistics were used to simultaneously evaluate the significance of 191 
observations for different case scenarios (i.e., differences over time or differences 192 
between clinical biochemistry tests/test groups), we took a conservative approach in 193 
selecting the significance level α by applying the Bonferroni correction.23 This multiple 194 
comparison correction technique minimizes the risk of obtaining false positive results by 195 
using an adjusted α for each single test. Single threshold values α were calculated in 196 
such a way that the family wise error probability pfwe (here adopted pfwe < 0.05) was 197 
retained at the global level.23 Accordingly, the significance level α for a single test was 198 
approximated by dividing the global error probability pfwe by the total number of 199 
independent tests.23 200 
Patient and public involvement 201 
No patients or general practitioners were involved in defining the research question or 202 
outcome measures nor were they engaged in the design or implementation this study. 203 
The study was approved by the Western Health and Social Care Trust (WHSCT). All 204 
identifiable information used for the purpose of the study was anonymised and not 205 
traceable to individual patients or general practitioners.  206 
Results 207 
Test ordering patterns 208 
We analysed the laboratory test request rates of 55 general practices within the 209 
catchment area of the WHSCT comprising a total of 316 382 (2011-12), 316 688 (2012-210 
13), 318 057 (2013-14), 319 383 (2014-2015), and 326 429 (2015-16) patients. Figure 211 
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1 shows the total number of 8 considered clinical biochemistry tests/test groups ordered 212 
during the study period of five consecutive years. The total number of ordered tests was 213 
523 111 (2011-12), 531 849 (2012-13), 531 583 (2013-14), 525 146 (2014-2015), and 214 
542 118 (2015-16) with electrolyte profiles found to be the most frequently ordered tests, 215 
making up approximately 30% of all requests in each year.  216 
The median number of adjusted test request rates between the 2011-12 and 2015-16 217 
decreased by 45.7% for urine albumin/creatinine ratio (ACR) (p < 0.000001) and 19.4% 218 
for lipid profiles (p < 0.000001). We observed a 60.6%, 36.6%, and 29.5% increase for 219 
HbA1c (p < 0.000001), immunoglobulins (p = 0.000007), and PSA (p = 0.0003) 220 
respectively. The Bonferroni adjusted probability p < 0.01 was used in testing for 221 
statistical significance (table 1). 222 
The between practice variation in the number of laboratory test requests is shown in 223 
Table 1. In the considered period, the Vari was lowest for electrolyte profiles (2.0-2.3), 224 
liver profiles (2.2-2.5), and HbA1c (2.2-2.9) and highest for immunoglobulins (19.2-69.8).. 225 
The number of outlier GP practices, i.e. practices with outlier ordering rates of laboratory 226 
tests contributed to the overall variability  (figure 2). The number of requested tests for 227 
thyroid profiles, HbA1c , and immunoglobulins per patient was over 3 times higher in the 228 
outlier GP practices (table 2). We however acknowledge that a statistical outlier in terms 229 
of test utilization is not necessarily an example of inappropriate practice. When 230 
compared to 2011-12, the variance in test utilization was 16.8% lower for electrolyte 231 
profiles, 15.3% for lipid profiles, 28.3% for thyroid profiles, and 23.5% for liver profiles in 232 
2015-16. For ACR, immunoglobulins, and HbA1c, the variance was 40%, 272%, and 233 
500% higher respectively.  234 
  235 
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Table 1. Overview of general statistics  
  EP Lipids PSA Thyroid HbA1c Liver ACR Immunos 
2011-2012         
Median, CI 520.5, (465.5, 545.0)  268.9, (242.2, 300.5)  53.2, (48.3, 79.8)  296.7, (266.2, 339.3)  1.8, (1.7, 2.0)  435.7, (394.3, 473.9)  1.9, (1.6, 2.1)  4.1, (3.1, 6.0)  
Range 267 - 1002 101.8 - 954.5 19.6 - 279.3 121 - 969.4 1.1 - 3.1 254 - 989.1 0.6 - 3.8 0.3 - 16.8 
Variance 15660.2 14519.1 2193.8 16320.0 0.2 16187.4 0.5 15.8 
Vari 2.3 3.4 7.0 3.3 2.2 2.5 3.4 18.3 
2012-2013         
Median, CI 491.7, (474.6, 542.5)  257.4, (236.1, 288.5)  59.2, (51.5, 88.3)  291.7, (266.5, 342.1)  2.0, (1.8, 2.2)  432.3, (399.0, 473.4)  1.7, (1.6, 2.0)  4.5, (3.6, 7.9)  
Range 283.6 - 1041.8 105.8 - 986.3 19.9 - 396.1 115.5 - 995.2 1.1 - 3.4 258.7 - 1016.4 0.5 - 4.8 0 - 24 
Variance 14299.4 14494.8 3896.4 17230.2 0.3 14997.6 0.5 28.0 
Vari 2.2 3.4 7.6 3.3 2.4 2.4 3.7 69.8 
2013-2014         
Median, CI 508.8, (469.2, 534.2)  239.3, (221.3, 271.2)  59.5, (54.9, 83.5) ) 264.3, (246.4, 318.0)  2.1, (1.9, 2.5)  408.3, (381.6, 453.3)  1.8, (1.6, 2.1)  4.4, (3.7, 8.4)  
Range 325.1 - 1014.9 111 - 950.7 23.1 - 527.6 141.5 - 962.2 1.3 - 4.6 267.1 - 987.8 0.7 - 4.7 0.5 - 24.8 
Variance 12831.5 13134.3 5153.6 15099.2 0.6 13739.4 0.5 36.2 
Vari 2.0 3.1 7.2 3.0 2.8 2.3 3.3 19.2 
2014-2015         
Median, CI 508.7, (476.5, 541.4)  224.0, (198.6, 248.4)  63.9, (55.6, 81.0)  260.4, (244.9, 311.8)  2.3, (2.2, 2.8)  422.4, (389.5, 458.4)  1.3, (1.2, 1.7)  5.9, (4.7, 9.9)  
Range 274.9 - 976.9 82.8 - 939.5 17.1 - 274 152.7 - 951.7 1.5 - 5.9 260.7 - 968 0.2 - 4 0 - 46.6 
Variance 12696.9 13814.0 2192.6 14324.6 0.8 13251.9 0.5 67.3 
Vari 2.1 3.5 6.3 3.0 2.9 2.3 4.7 33.6 
2015-2016         
Median, CI 527.5, (482.9, 556.9)  216.6, (193.2, 244.6)  68.9, (60.2, 86.7)  268.4, (251.6, 315.1)  2.8, (2.6, 3.3)  426.3, (391.7, 457.7)  1.0, (0.9, 1.3)  5.6, (5.0, 10.4)  
Range 316 - 925.3 96.9 - 846.5 26.4 - 296.9 142.5 - 857.2 1.7 - 8.1 274.6 - 898.3 0.1 - 5 0 - 33.9 
Variance 13048.3 12303.9 2961.0 11708.1 1.2 12378.9 0.7 58.9 
Vari 2.0 3.7 6.5 2.8 2.9 2.2 9.4 24.5 
236 
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Table 2. Number of requested tests per patients in outlier (O) and non-outlier (NO) GP practices. The requesting rates for: 1) electrolyte profiles, liver profiles, thyroid 
profiles, lipid profiles, and immunoglobulins are expressed as the number of tests per patient; 2) PSA – as the number of tests per male patient; 3) ARC and HbA1c – 
as the number of tests per patient with diabetes.  
 
Period 
Electrolyte 
profiles 
Lipid 
profiles 
PSA 
Thyroid 
profiles 
HbA1c 
Liver 
profiles 
ACR Immunos 
O NO O NO O NO O NO O NO O NO O NO O NO 
2011-2012 0.88 0.49 0.65 0.25 0.22 0.06 0.97 0.28 3.04 1.78 0.84 0.42 3.80 1.83 0.017 0.005 
2012-2013 0.58 0.50 0.99 0.25 0.28 0.07 1.00 0.29 3.32 1.99 1.02 0.42 4.61 1.80 0.024 0.006 
2013-2014 0.85 0.50 0.95 0.24 0.22 0.07 0.96 0.28 4.59 2.32 0.74 0.41 4.50 1.84 0.024 0.006 
2014-2015 0.78 0.50 0.52 0.21 0.22 0.07 0.95 0.27 5.00 2.46 0.97 0.42 3.96 1.43 0.034 0.008 
2015-2016 0.87 0.51 0.51 0.21 0.23 0.07 0.86 0.27 8.06 2.93 0.74 0.41 4.55 1.13 0.027 0.008 
237 
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Trends in the number and variation of test requests over time 238 
We observed no statistically significant linear trend in the median standardized number 239 
of laboratory tests over the period of investigation as indicated by the Mann-Kendal test 240 
p-values (figure 3). Furthermore, no linear trend was found in the annual changes in 241 
variation in test requesting rates (figure 3). Note that to control the false discovery rate 242 
in multiple comparisons (for 8 laboratory tests), the Bonferroni adjusted probability p < 243 
0.00625 was used in testing for statistical significance. 244 
Test ordering variation between general practices and explanatory factors 245 
The relationship between test requesting rates and potential explanatory factors was 246 
established based on the information on the number of ordered tests, patient 247 
demographics, and Quality and Outcomes Framework indicator scores obtained for the 248 
period 1 Apr 2015 – 31 Mar 2016.  249 
Demographic characteristics of patient population 250 
Proportion of the oldest age category of patients (> 75) constituted a relatively small 251 
group in each GP practice (mean = 6.1%, 95%CI = (5.7%,6.5%)). Hence, we combined 252 
the 65-74 and > 75 age categories to create a more meaningful group of patients in the 253 
older age band. We examined four tests for which differences in proportions of older 254 
patients were expected to be reflected in test requesting i.e. electrolyte profiles, liver 255 
profiles, lipid profiles, and thyroid profiles. Since we were unable to obtain a consolidated 256 
data on both gender and age of patients, we did not assess the relationship between the 257 
PSA requesting rates and the category of males aged 65 and over. We found no 258 
statistically significant relationship between the adjusted request rates of selected 259 
laboratory tests and the percentage distribution of patients of age over 65 260 
(supplementary table S1).  261 
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Since previous studies reported on a higher rate of testing of thyroid hormones in 262 
females,27 we looked at the strength of a relationship between the percentage of females 263 
in individual GP practices and requesting rates for thyroid profiles. We found no 264 
statistically significant association between these two characteristics (τ = -0.19, p = 0.05) 265 
(supplementary figure S1).  266 
In addition, we examined the effect of gender distribution on the standardized number of 267 
PSA tests, with the PSA ordering rates expected to be higher for GP practices with higher 268 
percentage of males (supplementary figure S2). No statistically significant correlation 269 
between these two variables was found (τ = 0.15 and p = 0.1). Note that we acknowledge 270 
the fact that a combined effect of sex and age distributions might have had a more 271 
significant effect on PSA requesting activity. However, the restricted access to such data 272 
limited the opportunity of more insightful analysis. 273 
Practice setting 274 
Figure 4 shows a temporal median-variance relationship of the standardized number of 275 
laboratory test requests for rural and urban areas. The median number of tests ordered 276 
annually by practices located in rural areas was higher by approximately 27-37% for 277 
PSA, 14-30% for lipid profiles, 14-38% for thyroid profiles, and 8-23% for liver profiles. 278 
For ACR and immunoglobulins the median requesting rates were lower in rural areas by 279 
1-27% and 18-57% respectively.  280 
Across five consecutive time periods, the Mann Whitney U (MWU) test showed 281 
significant differences between ‘rural’ and ‘urban’ distributions of laboratory test rates for 282 
lipid profiles (pMWU = 0.0004 in 2011-12, 0.001 in 2012-2013, and 0.0097 in 2013-14), 283 
thyroid profiles (pMWU = 0.009 in 2011-12), PSA (pMWU = 0.003 in 2015-2016), and 284 
immunoglobulins (pMWU = 0.0096 in 2015-16)  while no statistically significant rural-urban 285 
difference in between-practice variation in ordering rates was found for any of the studied  286 
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Table 3. The significance of differences in the distribution and variability in test request rates between GP practices located in rural and 
urban areas. pMWU: the Mann Whitney U p-value assessing differences in distributions of laboratory test rates between rural and urban 
practices. pFK: the Fligner-Killeen p-value referring to the significance level of differences in variances. In both cases, the Bonferroni-
corrected p < 0.01 was considered statistically significant (*). Bonferroni-corrected significance cut-off of α < 0.01 was established by dividing 
the family wise error probability pfwe < 0.05 by the number of tested associations i.e. 5 measurements over time. 
 
 Electrolyte 
profiles 
Lipid 
profiles 
PSA 
Thyroid 
profiles 
HbA1c 
Liver 
profiles 
ACR Immunoglobulins 
pMWU         
2011-2012 0.1 0.0004* 0.01 0.009* 0.3 0.03 0.4 0.2 
2012-2013 0.08 0.001* 0.03 0.01 0.7 0.02 0.5 0.4 
2013-2014 0.8 0.0097* 0.02 0.07 1.0 0.3 0.5 0.4 
2014-2015 0.6 0.01 0.02 0.1 0.9 0.3 0.5 0.03 
2015-2016 0.7 0.03 0.003* 0.07 0.7 0.3 0.08 0.0096* 
pFK         
2011-2012 0.4 0.5 0.03 0.2 0.6 1 0.2 0.8 
2012-2013 0.3 0.6 0.01 0.3 0.9 0.4 0.7 0.3 
2013-2014 0.2 0.6 0.06 0.03 0.5 0.7 1 0.5 
2014-2015 0.9 0.6 0.1 0.02 0.5 0.9 0.3 0.6 
2015-2016 0.7 0.7 0.2 0.2 0.2 0.7 0.8 0.1 
287 
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tests (table 3). Note that pMWU and pFK lower than Bonferroni-corrected significance cut-288 
off α < 0.01 (corrected for 5 different measurements over time) were considered 289 
statistically significant.  290 
Socioeconomic factors  291 
We observed no statistically significant relationship between the Multiple Deprivation 292 
Measure (MDM) and test requesting activity (supplementary table S2). Similarly, the 293 
relationship between the Health Deprivation & Disability rank and the standardized 294 
number of test requests was found insignificant for any of the considered tests 295 
(supplementary table S2). Note that to adjust for multiple comparisons at a family-wise 296 
simultaneous error rate of pfwe < 0.05, the Bonferroni-adjusted α  < 0.003125 (corrected 297 
for 16 different comparisons) was used to test for statistical significance.  298 
Quality and Outcomes Framework indicators 299 
To evaluate the relationship between standardized number of laboratory tests and QOF 300 
indicator scores, we looked at the management of diabetes. There are two main reasons 301 
for that. First, the guidelines for the management of diabetes are widely available to 302 
practitioners to improve clinical practice and care of diabetic patients. Secondly, HbA1c is 303 
a specific test in diabetes care and does not play an important role in the monitoring or 304 
diagnosis of any other condition. 305 
All practices achieved the maximum 17 points available under QOF clinical indicator 306 
DM007. All but nine practices attained the maximum 8 points available under DM008 307 
(range: 4.1-8.0) and 31 practices attained the maximum 10 points available under 308 
DM009 (range: 6.36-10.0). The relationship between the number of HbA1c tests 309 
performed and the GP practice effectiveness, as measured by the QOF overall 310 
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achievement rate (combined DM007, DM008, and DM009), was found statistically 311 
insignificant (τ = 0.12, p = 0.2).  312 
Discussion 313 
We evaluated temporal changes in variability and number of laboratory tests ordered by 314 
individual GP practices in the WHSCT. We also investigated a range of key 315 
demographic, socioeconomic, geographical, and clinical factors to assess whether any 316 
of these factors are likely to explain a part of the observed variation in requesting activity. 317 
Inter-practice variability in test requests expressed by the index of variability was the 318 
lowest for profile tests and the highest for HbA1c and immunoglobulins. This observation 319 
was consistent with previous studies.10,28,29  In addition, we observed a 23.3% decrease 320 
in profile tests (electrolyte, lipid, liver, and thyroid profiles combined) between 2011-12 321 
and 2015-16 (p = 0.009, the Bonferroni adjusted α < 0.01 used). This might have been 322 
related to the implementation of the demand optimization intervention in the WHSCT 323 
over the three year period from Apr 2012 to Mar 2015. The intervention was developed 324 
to support appropriate use of laboratory testing in the WHSCT and consisted of several 325 
elements including educational materials on the benefits of the optimal tests utilization, 326 
information on minimal retest intervals, the review of the test requesting processes, and 327 
financial incentive. Educational material covered the major clinical indications for a range 328 
of most commonly requested tests  (including profile tests) and was circulated 329 
electronically to all GPs. The educational material was supplemented by face-to-face 330 
educational sessions with primary care teams and presentation of data showing the local 331 
variability on test requesting rates. Furthermore, all primary care teams were asked to 332 
engage in the process of reviewing test requesting procedures within their practice (i.e. 333 
what staff are allowed to request tests and what is the process for test requesting), and 334 
to reflect on the information provided on their practice test requesting rates and ranking 335 
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in comparison to other practices. GPs also received a very small incentive to participate 336 
in the scrutiny of their requesting processes and activities to reflect the extra time that 337 
this involved. The 500% increase in variance of HbA1c ordering rates (statistically 338 
significant at the Bonferroni adjusted α < 0.01), on the other hand, may have been 339 
caused by between practice differences in the adoption of HbA1c as a diagnostic test 340 
(from 2012) and inconsistent implementation of new guidelines on appropriate rate of 341 
diabetes monitoring. This may indicate that recommended guidelines did not predispose 342 
GPs to change their perceptions on the value and role of HbA1c test in patient 343 
assessment.  344 
The inter-practitioner variations in test ordering were found unrelated to demographic 345 
and socioeconomic factors. We showed that distributions of patients’ age and sex had 346 
little impact on ordering rates for a predetermined set of pathology tests. The 347 
socioeconomic status of GP practice also did not appear to identify low or high 348 
requestors of laboratory tests. No significant relationship between test ordering and age, 349 
gender or deprivation measures was reported by other studies.6,30-32 350 
The practice location was found to be a significant factor associated with variability in 351 
use of lipid profiles, thyroid profiles, PSA, and immunoglobulins.. This may reflect the 352 
differences in clinical practice associated with the specific aspects of practice 353 
organisation and workflow in rural and urban practices as well as personal 354 
characteristics of general practitioners. The practice location was previously related to 355 
the between-practice variation in prescribing.33-35 Further studies are needed to explore 356 
in more detail the potential reasons for the rural-urban discrepancy in test utilization, 357 
especially that these differences appear to be significant only for some clinical 358 
biochemistry tests/test groups 359 
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Finally, we found no evidence of a significant correlation between test requesting rates 360 
and clinical outcomes. This observation is consistent with other studies.10 The fact that 361 
the majority of practices attained maximum points for the three target levels for 362 
HbA1c (59, 64, and 75 mmol/mol) implies that the glycaemic control was generally good 363 
and could not explain the variability in HbA1c testing. 364 
Note that we took a conservative approach in determining the significance cut-off α when 365 
evaluating the significance of observations for multiple comparisons (e.g., differences in 366 
laboratory test requests over time or differences in request rates between considered 367 
clinical biochemistry tests/test groups) by applying the Bonferroni correction. We are 368 
aware that while the Bonferroni adjustment decreases the risk of Type I errors i.e., a 369 
probability of a false significant result, this happens at cost of inflating Type II errors i.e., 370 
the probability of accepting the null hypothesis when the alternative is true. However, by 371 
applying this correction technique, we believe we reinforced confidence in the 372 
significance of our results. 373 
Implications for practice and research 374 
The findings of our study suggest that there may be considerable potential for the 375 
rationalization of test ordering through minimizing the between practice variability in test 376 
utilization. Yet, it is important to establish whether the observed variation is, and to what 377 
extent, associated with over-requesting (unnecessary repeat requesting of tests) in GP 378 
practices with high ordering rates or on the contrary, it reflects a failure to prescribe 379 
clinically indicated tests by GP practices characterized by low use of tests. Further 380 
analysis on the degree and detection of inappropriate use of laboratory resources in 381 
primary care could contribute to improving the consistency, efficiency, and cost-382 
effectiveness of patient diagnostics, monitoring, and treatment and hence, reduce 383 
unnecessary costs to patient care. 384 
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Further exploration of variations in requesting activity in the context of factors not 385 
considered in this study (e.g. practitioner-specific characteristics) may help identify and 386 
implement appropriate optimization strategies to manage demand for laboratory tests. 387 
Previous studies reported on the number of successful approaches in fostering best 388 
practice and reducing variation in test utilization including implementing locally agreed 389 
clinical guidelines, changing test order forms, incorporating clinical decision support 390 
tools with embedded retest interval rules, conducting audits of GPs on their request 391 
rates, and providing financial incentives.36-42 In fact, several studies showed that 392 
multifaceted interventions were most successful in optimizing laboratory demand.43,44 393 
Finally, it is essential to better understand implications of variability in laboratory test 394 
requesting for the cost and quality of care. In particular, an important question to be 395 
answered is whether or not the growing costs associated with increased use of 396 
laboratory services has led to commensurate benefits to the patient. 397 
Strengths and limitations 398 
Test requesting data were directly extracted from the HSC Business Object XI clinical 399 
information system that captures information on tests’ use from three clinical chemistry 400 
departments of Altnagelvin Area Hospital, Tyrone County Hospital, and South West 401 
Acute Hospital. Accordingly, our analysis was based on all available data regarding 402 
requesting activity in the N. Ireland Western Health and Social Care Trust (WHSCT) in 403 
the period of 1 Apr 2011 – 31 Mar 2016 and hence, was not subject to selection bias. 404 
Furthermore, our study provides a first comprehensive insight into the use of laboratory 405 
tests and factors accounting for the variation in between practice test utilization in the 406 
WHSCT primary care system. 407 
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Due to data unavailability, we were unable to investigate the relationship between 408 
laboratory use patterns and practitioner-specific characteristics including GP’s age, 409 
education, and medical training. Such analysis could help identify potential reasons 410 
behind variation in clinical practice. Besides the lack of information on the practitioners, 411 
the present study was limited by a paucity of research evidence in this area. We were 412 
also unable to retrieve consolidated data on both gender and age of patients registered 413 
in individual GP practices and therefore, assess the combined effect of sex and age 414 
distributions on test requesting activity. Furthermore, despite our attempt to maintain 415 
consistency by analysing laboratory test requests only from primary care medical 416 
practices that remained open throughout the study period, we acknowledge that some 417 
GPs in those practices could have been replaced, moved to alternative locations or quit 418 
direct patient care during the period of investigation. This could have an impact on the 419 
centre-associated requesting rates of laboratory tests. Finally, although the rationale of 420 
the study, research objectives, variables, inclusion criteria, outcome measures, and 421 
statistical methods to be used in our study were identified in advance to guide the 422 
analysis of the primary care use of laboratory tests in the WHSCT, the a-priori defined 423 
analysis plan was not published. We acknowledge that this could be perceived as a 424 
potential limitation of our study.  425 
Conclusion  426 
This study investigated the patterns and temporal changes in request rates across a 427 
range of frequently ordered laboratory tests. In addition, it explored potential factors of 428 
the inter-practice variability in the use of laboratory tests and found that differences in 429 
requesting activity appear unrelated to either demographic and socioeconomic 430 
characteristics of GP practices or clinical outcome indicators. Our results highlight the 431 
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need for further investigations to identify other potential factors that may account for the 432 
differences in test utilization between practitioners.  433 
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Figures 
Figure 1. The total number of 8 considered clinical biochemistry tests/test groups 
ordered by 55 general practices during the period 1 Apr 2011 – 31 Mar 2016.  
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Figure 2. Temporal variability of the standardized laboratory test requests for (a) 
electrolyte proﬁles, (b) lipid proﬁle, (c) prostate-speciﬁc antigen (PSA), (d) thyroid 
proﬁles, (e) liver proﬁles, (f) HbA1c, (g) urine albumin/creatinine ratio (ACR), and (h) 
immunoglobulins (Immunos) for 55 considered general practices. Each data point (dot): 
a single practice. Solid, horizontal line inside the box: median. Lower and upper "hinges" 
of the boxplots: 1st and 3rd quartiles, respectively. Lower and upper extremes of whiskers: 
interval boundaries of the non-outliers (black dots). Data outside interval: outliers. 
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Figure 3. Trend lines for median (blue) and variance (red) of the standardized number 
of (a) electrolyte proﬁles, (b) lipid proﬁle, (c) prostate-speciﬁc antigen (PSA), (d) thyroid 
proﬁles, (e) liver proﬁles, (f) HbA1c, (g) urine albumin/creatinine ratio (ACR), and (h) 
immunoglobulins (Immunos).  
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Figure 4. The temporal median-variance relationship of the standardized number of 
laboratory test requests across the years for (a) electrolyte proﬁles (EP), (b) lipid proﬁle 
(LP), (c) prostate-speciﬁc antigen (PSA), (d) thyroid proﬁles (TP), (e) liver proﬁles (LFT), 
(f) HbA1c, (g) urine albumin/creatinine ratio (ACR), and (h) immunoglobulins (Immunos). 
Circle/triangle: rural/urban general practices. 
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Supplementary Table S1. The relationship between test requesting rates and demographic characteristics of patient population. Kendall's correlation 
coefficient tau: τ. p-value associated with τ: pKendall. Bonferroni-corrected significance cut-off: α = pfwe/n < 0.0125 where pfwe < 0. 05 is the family wise error 
probability and n = 4 is the number of tested associations. 
 
Age group Electrolyte profiles Lipid profiles Thyroid profiles Liver profiles 
 ≥ 65 years old 
ᴛ 
pKendall 
 
0.21 
0.04 
 
 
0.23 
0.02 
 
0.08 
0.4 
 
0.20 
0.05 
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Supplementary Figure S2. The relationship between the percentage of females in individual GP practices and requesting rates for thyroid profiles. 
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Supplementary Figure S3. The relationship between the percentage of males in individual GP practices and requesting rates for PSA. 
 
41 
 
Supplementary Table S4. The relationship between test requesting rates and socioeconomic factors. Kendall's correlation coefficient tau: τ; p-value 
associated with τ: pKendall. Bonferroni-corrected significance cut-off: α = pfwe/n < 0.003125 where pfwe < 0. 05 is the family wise error probability and n = 16 is 
the number of tested associations. 
  
Electrolyte 
profiles 
Lipid 
profiles 
PSA 
Thyroid 
profiles 
HbA1c 
Liver 
profiles 
ACR Immunoglobulins 
Multiple Deprivation 
Measure 
        
ᴛ 0.034 0.116 0.180 0.119 0.012 0.083 -0.094 -0.167 
pKendall 0.7 0.2 0.05 0.2 0.9 0.4 0.3 0.08 
Health Deprivation & 
Disability 
        
ᴛ 0.124 0.256 0.209 0.239 0.062 0.185 -0.021 -0.156 
pKendall 0.2 0.007 0.013 0.01 0.5 0.05 0.8 0.1 
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